Home>>Carfentanil-13C6 (CRM)

Carfentanil-13C6 (CRM) (Synonyms: Carfentanyl-13C6, 4-carbomethoxy Fentanyl-13C6)

Catalog No.GC48578

Products are for research use only. Not for human use. We do not sell to patients.

Carfentanil-13C6 (CRM) Chemical Structure

Size Price Stock Qty
100µg
$197.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Carfentanil-13C6 (CRM) is a certified reference material intended for use as an internal standard for the quantification of carfentanil by GC- or LC-MS. Carfentanil is categorized as an opioid.1 It has been found as an adulterant in heroin and is linked to emergency room visits and fatalities.2 Carfentanil is highly abused and associated with fatal overdoses.3 Carfentanil-13C6 is regulated as a Schedule II compound in the United States. Carfentanil-13C6 (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

1.Submaranian, G., Parterlini, M.G., Portoghese, S., et al.Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptorJ. Med. Chem.43(3)381-391(2000) 2.Shanks, K.G., and Behonick, G.S.Detection of carfentanil by LC-MS-MS and reports of associated fatalities in the USAJ. Analyt. Toxicol.41(6)466-472(2017) 3.Misailidi, N., Papoutsis, I., Nikolaou, P., et al.Fentanyls continue to replace heroin in the drug arena: The cases of ocfentanil and carfentanilForensic Toxicol.36(1)12-32(2017)

Reviews

Review for Carfentanil-13C6 (CRM)

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Carfentanil-13C6 (CRM)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.